News posted 1 August, 2019

MFT welcomes staff from Liverpool Women’s as part of the new North West Genomic Laboratory Hub

Manchester University NHS Foundation Trust (MFT) is delighted to welcome staff from Liverpool Women’s NHS Foundation Trust today (1st August) as part of a ground-breaking initiative to harness the power of genomic technology and science to improve the health of our population.

The Liverpool Women’s genomic laboratory staff will work within the genomics department as part of the North West Genomic Laboratory Hub (NW GLH).

The NW GLH, alongside another six GLHs from across the country, make up the new national Genomic Medicine Service. This Service builds on the legacy of the successful 100,000 Genomes Project and will make available in routine clinical care the benefits of whole genome sequencing for both rare disease and cancer patients.

Karen Connolly, Chief Executive of Saint Mary’s Hospital, said: “We are delighted to welcome staff from Liverpool Women’s Hospital so that by working together we can make changes to improve outcomes for the people of the North West region.”

Sitting within Saint Mary’s Hospital the NW GLH aims to address the variation in quality and access to genetic testing across the North West, especially in cancer, by:

  • Improving the information available in terms of spending on testing and the type of tests being performed
  • Enhancing genetic testing for cancer, and rare inherited diseases. This will improve both patient diagnosis and treatment decisions
  • Creating opportunities to link with academic and industry partners on research and development programmes
  • Broadening our understanding of the cause of disease and the effectiveness of the interventions that will be offered to patients and their families to help deliver high quality care for all, now and for future generations.